Whole genome sequencing of Mycobacterium tuberculosis clinical isolates from India reveals genetic heterogeneity and region-specific variations that might affect drug susceptibility

Jayshree Advani, Renu Verma, Oishi Chatterjee, Praveen Kumar Pachouri, Prashant Upadhyay, Rajesh Singh, Jitendra Yadav, Farah Naaz, Raju Ravikumar, Shashidhar Buggi, Mrutyunjay Suar, Umesh D. Gupta, Akhilesh Pandey, Devendra S. Chauhan, Srikanth Prasad Tripathy, Harsha Gowda, T. S.Keshava Prasad

Research output: Contribution to journalArticle

Abstract

Whole genome sequencing (WGS) of Mycobacterium tuberculosis has been constructive in understanding its evolution, genetic diversity and the mechanisms involved in drug resistance. A large number of sequencing efforts from across the globe have revealed genetic diversity among clinical isolates and the genetic determinants for their resistance to anti-tubercular drugs. Considering the high TB burden in India, the availability of WGS studies is limited. Here we present, WGS results of 200 clinical isolates of M. tuberculosis from North India which are categorized as sensitive to first-line drugs, mono-resistant, multi-drug resistant and pre-extensively drug resistant isolates. WGS revealed that 20% of the isolates were co-infected with M. tuberculosis and non-tuberculous mycobacteria species. We identified 12, 802 novel genetic variations in M. tuberculosis isolates including 343 novel SNVs in 38 genes which are known to be associated with drug resistance and are not currently used in the diagnostic kits for detection of drug resistant TB. We also identified M. tuberculosis lineage 3 to be predominant in the northern region of India. Additionally, several novel SNVs, which may potentially confer drug resistance were found to be enriched in the drug resistant isolates sampled. This study highlights the significance of employing WGS in diagnosis and for monitoring further development of MDR-TB strains.

Original languageEnglish (US)
Article number309
JournalFrontiers in Microbiology
Volume10
Issue numberFEB
DOIs
StatePublished - Jan 1 2019

Fingerprint

Genetic Heterogeneity
Mycobacterium tuberculosis
India
Genome
Drug Resistance
Pharmaceutical Preparations
Mycobacterium
Genes

Keywords

  • Fluoroquinolones
  • Metagenomics
  • Molecular genotyping
  • Mycobacterial genetic heterogeneity
  • Next generation sequencing

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Whole genome sequencing of Mycobacterium tuberculosis clinical isolates from India reveals genetic heterogeneity and region-specific variations that might affect drug susceptibility. / Advani, Jayshree; Verma, Renu; Chatterjee, Oishi; Pachouri, Praveen Kumar; Upadhyay, Prashant; Singh, Rajesh; Yadav, Jitendra; Naaz, Farah; Ravikumar, Raju; Buggi, Shashidhar; Suar, Mrutyunjay; Gupta, Umesh D.; Pandey, Akhilesh; Chauhan, Devendra S.; Tripathy, Srikanth Prasad; Gowda, Harsha; Prasad, T. S.Keshava.

In: Frontiers in Microbiology, Vol. 10, No. FEB, 309, 01.01.2019.

Research output: Contribution to journalArticle

Advani, J, Verma, R, Chatterjee, O, Pachouri, PK, Upadhyay, P, Singh, R, Yadav, J, Naaz, F, Ravikumar, R, Buggi, S, Suar, M, Gupta, UD, Pandey, A, Chauhan, DS, Tripathy, SP, Gowda, H & Prasad, TSK 2019, 'Whole genome sequencing of Mycobacterium tuberculosis clinical isolates from India reveals genetic heterogeneity and region-specific variations that might affect drug susceptibility', Frontiers in Microbiology, vol. 10, no. FEB, 309. https://doi.org/10.3389/fmicb.2019.00309
Advani, Jayshree ; Verma, Renu ; Chatterjee, Oishi ; Pachouri, Praveen Kumar ; Upadhyay, Prashant ; Singh, Rajesh ; Yadav, Jitendra ; Naaz, Farah ; Ravikumar, Raju ; Buggi, Shashidhar ; Suar, Mrutyunjay ; Gupta, Umesh D. ; Pandey, Akhilesh ; Chauhan, Devendra S. ; Tripathy, Srikanth Prasad ; Gowda, Harsha ; Prasad, T. S.Keshava. / Whole genome sequencing of Mycobacterium tuberculosis clinical isolates from India reveals genetic heterogeneity and region-specific variations that might affect drug susceptibility. In: Frontiers in Microbiology. 2019 ; Vol. 10, No. FEB.
@article{ee6b5952b6294f66b13469c1a80f3483,
title = "Whole genome sequencing of Mycobacterium tuberculosis clinical isolates from India reveals genetic heterogeneity and region-specific variations that might affect drug susceptibility",
abstract = "Whole genome sequencing (WGS) of Mycobacterium tuberculosis has been constructive in understanding its evolution, genetic diversity and the mechanisms involved in drug resistance. A large number of sequencing efforts from across the globe have revealed genetic diversity among clinical isolates and the genetic determinants for their resistance to anti-tubercular drugs. Considering the high TB burden in India, the availability of WGS studies is limited. Here we present, WGS results of 200 clinical isolates of M. tuberculosis from North India which are categorized as sensitive to first-line drugs, mono-resistant, multi-drug resistant and pre-extensively drug resistant isolates. WGS revealed that 20{\%} of the isolates were co-infected with M. tuberculosis and non-tuberculous mycobacteria species. We identified 12, 802 novel genetic variations in M. tuberculosis isolates including 343 novel SNVs in 38 genes which are known to be associated with drug resistance and are not currently used in the diagnostic kits for detection of drug resistant TB. We also identified M. tuberculosis lineage 3 to be predominant in the northern region of India. Additionally, several novel SNVs, which may potentially confer drug resistance were found to be enriched in the drug resistant isolates sampled. This study highlights the significance of employing WGS in diagnosis and for monitoring further development of MDR-TB strains.",
keywords = "Fluoroquinolones, Metagenomics, Molecular genotyping, Mycobacterial genetic heterogeneity, Next generation sequencing",
author = "Jayshree Advani and Renu Verma and Oishi Chatterjee and Pachouri, {Praveen Kumar} and Prashant Upadhyay and Rajesh Singh and Jitendra Yadav and Farah Naaz and Raju Ravikumar and Shashidhar Buggi and Mrutyunjay Suar and Gupta, {Umesh D.} and Akhilesh Pandey and Chauhan, {Devendra S.} and Tripathy, {Srikanth Prasad} and Harsha Gowda and Prasad, {T. S.Keshava}",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fmicb.2019.00309",
language = "English (US)",
volume = "10",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media S. A.",
number = "FEB",

}

TY - JOUR

T1 - Whole genome sequencing of Mycobacterium tuberculosis clinical isolates from India reveals genetic heterogeneity and region-specific variations that might affect drug susceptibility

AU - Advani, Jayshree

AU - Verma, Renu

AU - Chatterjee, Oishi

AU - Pachouri, Praveen Kumar

AU - Upadhyay, Prashant

AU - Singh, Rajesh

AU - Yadav, Jitendra

AU - Naaz, Farah

AU - Ravikumar, Raju

AU - Buggi, Shashidhar

AU - Suar, Mrutyunjay

AU - Gupta, Umesh D.

AU - Pandey, Akhilesh

AU - Chauhan, Devendra S.

AU - Tripathy, Srikanth Prasad

AU - Gowda, Harsha

AU - Prasad, T. S.Keshava

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Whole genome sequencing (WGS) of Mycobacterium tuberculosis has been constructive in understanding its evolution, genetic diversity and the mechanisms involved in drug resistance. A large number of sequencing efforts from across the globe have revealed genetic diversity among clinical isolates and the genetic determinants for their resistance to anti-tubercular drugs. Considering the high TB burden in India, the availability of WGS studies is limited. Here we present, WGS results of 200 clinical isolates of M. tuberculosis from North India which are categorized as sensitive to first-line drugs, mono-resistant, multi-drug resistant and pre-extensively drug resistant isolates. WGS revealed that 20% of the isolates were co-infected with M. tuberculosis and non-tuberculous mycobacteria species. We identified 12, 802 novel genetic variations in M. tuberculosis isolates including 343 novel SNVs in 38 genes which are known to be associated with drug resistance and are not currently used in the diagnostic kits for detection of drug resistant TB. We also identified M. tuberculosis lineage 3 to be predominant in the northern region of India. Additionally, several novel SNVs, which may potentially confer drug resistance were found to be enriched in the drug resistant isolates sampled. This study highlights the significance of employing WGS in diagnosis and for monitoring further development of MDR-TB strains.

AB - Whole genome sequencing (WGS) of Mycobacterium tuberculosis has been constructive in understanding its evolution, genetic diversity and the mechanisms involved in drug resistance. A large number of sequencing efforts from across the globe have revealed genetic diversity among clinical isolates and the genetic determinants for their resistance to anti-tubercular drugs. Considering the high TB burden in India, the availability of WGS studies is limited. Here we present, WGS results of 200 clinical isolates of M. tuberculosis from North India which are categorized as sensitive to first-line drugs, mono-resistant, multi-drug resistant and pre-extensively drug resistant isolates. WGS revealed that 20% of the isolates were co-infected with M. tuberculosis and non-tuberculous mycobacteria species. We identified 12, 802 novel genetic variations in M. tuberculosis isolates including 343 novel SNVs in 38 genes which are known to be associated with drug resistance and are not currently used in the diagnostic kits for detection of drug resistant TB. We also identified M. tuberculosis lineage 3 to be predominant in the northern region of India. Additionally, several novel SNVs, which may potentially confer drug resistance were found to be enriched in the drug resistant isolates sampled. This study highlights the significance of employing WGS in diagnosis and for monitoring further development of MDR-TB strains.

KW - Fluoroquinolones

KW - Metagenomics

KW - Molecular genotyping

KW - Mycobacterial genetic heterogeneity

KW - Next generation sequencing

UR - http://www.scopus.com/inward/record.url?scp=85065925148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065925148&partnerID=8YFLogxK

U2 - 10.3389/fmicb.2019.00309

DO - 10.3389/fmicb.2019.00309

M3 - Article

C2 - 30863380

AN - SCOPUS:85065925148

VL - 10

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

IS - FEB

M1 - 309

ER -